Filing Details
- Accession Number:
- 0001104659-11-065233
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-11-18 18:54:36
- Reporting Period:
- 2011-11-16
- Filing Date:
- 2011-11-18
- Accepted Time:
- 2011-11-18 18:54:36
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1126234 | Newlink Genetics Corp | NLNK | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1512133 | J. David Lundquist | C/O Newlink Genetics Corporation 2503 South Loop Dr., Suite 5100 Ames IA 50010 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-11-16 | 13,267 | $0.00 | 24,642 | No | 4 | C | Indirect | By David J. Lundquist Revocable Trust |
Common Stock | Acquisiton | 2011-11-16 | 9,523 | $0.00 | 34,165 | No | 4 | C | Indirect | By David J. Lundquist Revocable Trust |
Common Stock | Acquisiton | 2011-11-16 | 10,856 | $0.00 | 45,021 | No | 4 | C | Indirect | By David J. Lundquist Revocable Trust |
Common Stock | Acquisiton | 2011-11-16 | 27,609 | $0.00 | 72,630 | No | 4 | C | Indirect | By David J. Lundquist Revocable Trust |
Common Stock | Acquisiton | 2011-11-16 | 15,000 | $7.00 | 87,630 | No | 4 | P | Indirect | By David J. Lundquist Revocable Trust |
Common Stock | Disposition | 2011-11-18 | 87,630 | $0.00 | 0 | No | 5 | G | Indirect | By David J. Lundquist Revocable Trust |
Common Stock | Acquisiton | 2011-11-18 | 43,815 | $0.00 | 43,815 | No | 5 | G | Indirect | By David J. Lundquist 2011 Exempt Trust |
Common Stock | Acquisiton | 2011-11-18 | 43,815 | $0.00 | 43,815 | No | 5 | G | Indirect | By David J. Lundquist 2011 Nonexempt Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Indirect | By David J. Lundquist Revocable Trust |
No | 4 | C | Indirect | By David J. Lundquist Revocable Trust |
No | 4 | C | Indirect | By David J. Lundquist Revocable Trust |
No | 4 | C | Indirect | By David J. Lundquist Revocable Trust |
No | 4 | P | Indirect | By David J. Lundquist Revocable Trust |
No | 5 | G | Indirect | By David J. Lundquist Revocable Trust |
No | 5 | G | Indirect | By David J. Lundquist 2011 Exempt Trust |
No | 5 | G | Indirect | By David J. Lundquist 2011 Nonexempt Trust |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series AA Preferred Stock | Disposition | 2011-11-16 | 27,780 | $0.00 | 27,780 | $0.00 |
Common Stock | Series B Preferred Stock | Disposition | 2011-11-16 | 19,999 | $0.00 | 19,999 | $0.00 |
Common Stock | Series C Preferred Stock | Disposition | 2011-11-16 | 20,000 | $0.00 | 20,000 | $0.00 |
Common Stock | Series E Preferred Stock | Disposition | 2011-11-16 | 5,257 | $0.00 | 5,257 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect |
Footnotes
- Every one share of Series AA Preferred Stock automatically converted into approximately 0.476 shares of common stock upon the closing of the Issuer's initial public offering and had no expiration date. Includes 39 shares acquired by dividend issued upon conversion of Series AA Preferred Stock.
- Every one share of Series B Preferred Stock automatically converted into approximately 0.476 shares of common stock upon the closing of the Issuer's initial public offering and had no expiration date.
- Every one share of Series C Preferred Stock automatically converted into approximately 0.542 shares of common stock upon the closing of the Issuer's initial public offering and had no expiration date.
- Every one share of Series E Preferred Stock automatically converted into approximately 5.252 shares of common stock upon the closing of the Issuer's initial public offering and had no expiration date.
- The shares were purchased in the Issuer's initial public offering.